Acumen Pharmaceuticals, Inc. (ABOS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.05
Day's range
$3.3

Acumen Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 20.99 M $49.54 M   40.59% 34.66%
SANDS CAPITAL VENTURES, LLC 05/08/2026 3.72 M $8.78 M   8.87% 6.14%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 2.45 M $5.78 M   161.25% 4.05%
FRANKLIN RESOURCES INC 05/13/2026 2.31 M $5.44 M   0.00% 3.81%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 2.16 M $5.09 M   141.96% 3.56%
KNOLLWOOD INVESTMENT ADVISORY, LLC 05/14/2026 1.63 M $3.84 M   0.00% 2.69%
05/15/2026 1.51 M $3.55 M   100.00% 2.49%
FMR LLC 05/15/2026 1.16 M $2.73 M   -42.92% 1.91%
IKARIAN CAPITAL, LLC 05/15/2026 1.05 M $2.49 M   314.37% 1.74%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 968.94 K $2.29 M   33.65% 1.60%
PATHSTONE HOLDINGS, LLC 05/11/2026 859.11 K $2.03 M   0.00% 1.42%
SG AMERICAS SECURITIES, LLC 04/16/2026 719.26 K $1.70 M   79.34% 1.19%
MILLENNIUM MANAGEMENT LLC 05/15/2026 659.68 K $1.56 M   12.93% 1.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 601.48 K $1.42 M   61.17% 0.99%
TWO SIGMA INVESTMENTS, LP 05/15/2026 530.81 K $1.25 M   270.62% 0.88%
LAURION CAPITAL MANAGEMENT LP 05/14/2026 525.44 K $1.24 M   -39.40% 0.87%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 473.95 K $1.12 M   12.02% 0.78%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 416.24 K $982.76 K   1.47% 0.69%
BANK OF AMERICA CORP /DE/ 05/18/2026 320.22 K $755.71 K   33.34% 0.53%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 273.01 K $644.31 K   589.69% 0.45%
GOLDMAN SACHS GROUP INC 05/15/2026 206.68 K $487.77 K   75.38% 0.34%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 199.23 K $470.17 K   100.00% 0.33%
MARSHALL WACE, LLP 05/15/2026 192.89 K $455.22 K   822.60% 0.32%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 185.85 K $435.00 K   21.65% 0.31%
BLACKROCK, INC. 05/13/2026 178.33 K $420.85 K   5.20% 0.29%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 176.17 K $415.76 K   3.53% 0.29%
STATE STREET CORP 05/15/2026 151.73 K $358.08 K   51.46% 0.25%
MORGAN STANLEY 05/15/2026 144.58 K $341.22 K   -13.37% 0.24%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 120.39 K $284.12 K   150.89% 0.20%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 119.76 K $281.76 K   144.09% 0.20%
CATALYST FINANCIAL PARTNERS LLC 05/12/2026 89.70 K $211.69 K   0.00% 0.15%
JANE STREET GROUP, LLC 05/12/2026 89.66 K $211.60 K   -36.91% 0.15%
PFG INVESTMENTS, LLC 04/27/2026 80.85 K $190.81 K   325.53% 0.13%
NORTHERN TRUST CORP 05/14/2026 75.21 K $177.50 K   0.00% 0.12%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 67.38 K $159.01 K   85.27% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 56.00 K $132.16 K   100.00% 0.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 55.90 K $131.92 K   100.00% 0.09%
PROSPERA FINANCIAL SERVICES INC 04/14/2026 50.00 K $118.00 K   0.00% 0.08%
CATALYST FUNDS MANAGEMENT PTY LTD 05/11/2026 45.60 K $107.62 K   54.05% 0.08%
VERDAD ADVISERS, LP 05/15/2026 37.28 K $87.98 K   100.00% 0.06%
UBS GROUP AG 05/05/2026 37.15 K $87.67 K   72.28% 0.06%
RANGELEY CAPITAL, LLC 05/15/2026 35.00 K $82.60 K   100.00% 0.06%
BARCLAYS PLC 05/15/2026 30.68 K $72.40 K   2.29% 0.05%
INTREPID FINANCIAL PLANNING GROUP LLC 05/13/2026 30.15 K $71.15 K   0.00% 0.05%
OMERS ADMINISTRATION CORP 05/15/2026 28.60 K $67.50 K   27.37% 0.05%
AXQ CAPITAL, LP 05/13/2026 28.49 K $67.23 K   100.00% 0.05%
JANE STREET GROUP, LLC 05/12/2026 23.70 K $55.93 K   100.00% 0.04%
INDEPENDENT ADVISOR ALLIANCE 05/12/2026 19.00 K $44.84 K   0.00% 0.03%
JANE STREET GROUP, LLC 05/12/2026 18.90 K $44.60 K   100.00% 0.03%
PINNACLE ASSOCIATES LTD 04/22/2026 18.02 K $42.53 K   0.00% 0.03%

Acumen Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 101 institutional investors and hedge funds held shares of Acumen Pharmaceuticals Inc. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 20.99 M

Sands Capital Ventures, LLC: 3.72 M

Alyeska Investment Group, L.P.: 2.45 M

FRANKLIN RESOURCES INC: 2.31 M

ADAR1 Capital Management, LLC: 2.16 M

Knollwood Investment Advisory, LLC: 1.63 M

75.96% of Acumen Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 49.50 M shares in the last 24 months. This purchase volume represents approximately $155.43 M in transactions.